1 year return (CAGR)
48.63%
Lumos Pharma Inc Exchange (NASDAQ, USD)
LUMO
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-16.22%
5 year return (CAGR)
-22.46%
10 year return (CAGR)
-35.26%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
37.54M
Price/Sales
17.02
Ent value
36.56M
Price/Book
7.64
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-20.27%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 4.33 |
| Daily high | 4.39 |
| Daily low | 4.33 |
| Daily Volume | 482K |
| 1y analyst estimate | 4.25 |
| Beta | 0.33 |
| EPS (TTM) | -4.19 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LUMO | S&P500 | |
| Current price drop from All-time high | -99.15% | -0.06% |
| Highest price drop | -99.72% | -56.47% |
| Date of highest drop | 18 Jul 2024 | 9 Mar 2009 |
| Avg drop from high | -70.57% | -10.68% |
| Avg time to new high | 44 days | 12 days |
| Max time to new high | 2435 days | 1805 days |
News
No items found